ArticleJournal of cutaneous pathology2026
A Rare Case of Cutaneous Crystal-Storing Histiocytosis With Kappa Light Chain Restriction and Unusual BCL6 Expression.
Article in Journal of cutaneous pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Crystal-storing histiocytosis (CSH) is a rare histopathologic phenomenon characterized by the accumulation of crystalline material within histiocytes, most often associated with lymphoplasmacytic or plasma cell neoplasms. Cutaneous involvement is uncommon and may present diagnostic challenges. We report a 63-year-old woman with indurated plaques involving the face, chest, and upper extremities. Skin biopsies revealed aggregates of epithelioid histiocytes containing intracytoplasmic crystalline material, admixed with a lymphoplasmacytic infiltrate. The histiocytic cells were positive for CD68 and CD163. Plasma cells showed IgG kappa light chain restriction, and molecular studies demonstrated a monoclonal immunoglobulin heavy chain gene rearrangement. Serum studies identified an IgG kappa monoclonal gammopathy, supporting a diagnosis of cutaneous involvement by a B-cell lymphoma with plasmacytic differentiation associated with localized CSH. Weak, nonspecific immunoreactivity with the BRAF V600E antibody was observed; however, next-generation sequencing did not identify a BRAF V600E mutation, supporting interpretation as antibody cross-reactivity. A subset of histiocytes showed weak BCL6 expression of uncertain significance. This case highlights the importance of recognizing cutaneous CSH, emphasizes evaluation for an underlying lymphoproliferative disorder, and illustrates immunohistochemical pitfalls that may complicate interpretation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.